Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/18981

Target Organs and Levels of Evidence for GMM-10

Toxicology Study of Diispropylcarbodiimide (CASRN 693-13-0) in Genetically Modified (FVB Tg.AC Hemizygous) Mice and Carcinogenicity Study of Diispropylcarbodiimide in Genetically Modified [B6.129-Trp53tm1Brd (N5) Haploinsufficient] Mice (Dermal Studies)

Chemical (Study Title)
CASRN
Peer Review Date Primary Uses Route/Exposure Levels Study Laboratory
Diisopropylcarbodiimide
693-13-0
09/28/2005 As a peptide coupling reagent; as a condensing reagent in dipeptide synthesis; in preparation of polyimide precursor coatings for electrophoretic image display fabrication; as a military nerve agent stabilizer. Topical Application
Female Mice: 0, 4.38, 8.75, 17.5, 35, or 70 mg/kg; 10/group
BioReliance, Inc
Levels of evidence information forToxicology Study of Diisopropylcarbodiimide in Female Tg.AC Hemizygous Mice
  Female Tg.AC Hemizygous Mice
  20 Weeks
Neoplastic Lesions None
Non-Neoplastic Lesions None




Levels of evidence information forCarcinogenesis Study of Diisopropylcarbodiimide in Female p53 Haploinsufficient Mice
  Female p53 Haploinsufficient Mice
  27 Weeks
Levels of Evidence No Evidence
Neoplastic Lesions None
Non-Neoplastic Lesions
  • Skin: epidermal hyperplasia